Abstract 1968: Discovery of a highly potent and selective FGFR2 inhibitor for FGFR2-driven cancers
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.am2024-1968
Abstract: Fibroblast growth factor receptor 2 (FGFR2) is a clinically validated target and frequently altered in many solid tumors. The resulting oncogenic driver alterations often drive multiple solid tumors. Therefore, targeting FGFR2 has broad therapeutic potential.… read more here.
Keywords: potent selective; fgfr2 inhibitor; fgfr2 driven; selective fgfr2 ... See more keywords